Reassessing The Changing Outlook For Bristol-Myers Squibb Co. (BMY)
BlackRock Fund Advisors recently announced the acquisition of new stake in Bristol-Myers Squibb Co. (NYSE:BMY). The institutional investor has increased its shareholding in the Healthcare company by 0.27% to 110.79 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 5.45% valued currently at $5.47 billion. In addition, Capital […]
Bristol-Myers Squibb Co. (BMY) Testing Investors’ Patience Right Now
With over 44.12 million Bristol-Myers Squibb Co. (BMY) shares trading Friday and a closing price of $50.89 on the day, the dollar volume was approximately $2.25 billion. The shares have shown a negative half year performance of -23.08% and its price on 12/15/23 lost nearly -1.13%. Currently, there are 2.10B common shares owned by the […]
